Sandra Milligan - Head of Research & Development at Organon & Co.

Insider Transactions and Holdings

Entity Type
Individual
Role
Head of Research & Development
Stock Symbol
OGN on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Sandra Milligan since 7/6/2023

Holdings reported by Sandra Milligan for Organon & Co.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 28,599 $616 K $21.53 May 4, 2023 Direct
Restricted Stock Units 4,984 $107 K $21.53 May 4, 2023 Direct Common Stock

Transactions reported by Sandra Milligan for Organon & Co.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership